Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant

被引：0
|
作者：
Shuai Xia
Jasper Fuk-Woo Chan
Lijue Wang
Fanke Jiao
Kenn Ka-Heng Chik
Hin Chu
Qiaoshuai Lan
Wei Xu
Qian Wang
Chao Wang
Kwok-Yung Yuen
Lu Lu
Shibo Jiang
机构：
[1] Fudan University,Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Frontiers Science Center of Pathogenic Microbes and Infection, Shanghai Institute of Infectious Disease and Biosecurity
[2] The University of Hong Kong,State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine
[3] The University of Hong Kong-Shenzhen Hospital,Department of Clinical Microbiology and Infection Control
[4] Hong Kong Science and Technology Park,Centre for Virology, Vaccinology and Therapeutics
[5] Beijing Institute of Pharmacology and Toxicology,State Key Laboratory of Toxicology and Medical Countermeasures
来源：
Cell Research | 2022年 / 32卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：404 / 406
页数：2
相关论文
共 50 条
  • [1] Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant
    Xia, Shuai
    Chan, Jasper Fuk-Woo
    Wang, Lijue
    Jiao, Fanke
    Chik, Kenn Ka-Heng
    Chu, Hin
    Lan, Qiaoshuai
    Xu, Wei
    Wang, Qian
    Wang, Chao
    Yuen, Kwok-Yung
    Lu, Lu
    Jiang, Shibo
    CELL RESEARCH, 2022, 32 (04) : 404 - 406
  • [2] SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors
    Xia, Shuai
    Wang, Lijue
    Jiao, Fanke
    Yu, Xueying
    Xu, Wei
    Huang, Ziqi
    Li, Xicheng
    Wang, Qian
    Zhu, Yun
    Man, Qiuhong
    Jiang, Shibo
    Lu, Lu
    EMERGING MICROBES & INFECTIONS, 2023, 12 (01)
  • [3] A Palmitic Acid-Conjugated, Peptide-Based pan-CoV Fusion Inhibitor Potently Inhibits Infection of SARS-CoV-2 Omicron and Other Variants of Concern
    Lan, Qiaoshuai
    Chan, Jasper Fuk-Woo
    Xu, Wei
    Wang, Lijue
    Jiao, Fanke
    Zhang, Guangxu
    Pu, Jing
    Zhou, Jie
    Xia, Shuai
    Lu, Lu
    Yuen, Kwok-Yung
    Jiang, Shibo
    Wang, Qian
    VIRUSES-BASEL, 2022, 14 (03):
  • [4] Peptide-Based Inhibitors for SARS-CoV-2 and SARS-CoV
    Panchal, Disha
    Kataria, Jeena
    Patel, Kamiya
    Crowe, Kaytlyn
    Pai, Varun
    Azizogli, Abdul-Rahman
    Kadian, Neil
    Sanyal, Sreya
    Roy, Abhishek
    Dodd-o, Joseph
    Acevedo-Jake, Amanda M.
    Kumar, Vivek A.
    ADVANCED THERAPEUTICS, 2021, 4 (10)
  • [5] Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation
    Xia, Shuai
    Lan, Qiaoshuai
    Zhu, Yun
    Wang, Chao
    Xu, Wei
    Li, Yutang
    Wang, Lijue
    Jiao, Fanke
    Zhou, Jie
    Hua, Chen
    Wang, Qian
    Cai, Xia
    Wu, Yang
    Gao, Jie
    Liu, Huan
    Sun, Ge
    Muench, Jan
    Kirchhoff, Frank
    Yuan, Zhenghong
    Xie, Youhua
    Sun, Fei
    Jiang, Shibo
    Lu, Lu
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [6] Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation
    Shuai Xia
    Qiaoshuai Lan
    Yun Zhu
    Chao Wang
    Wei Xu
    Yutang Li
    Lijue Wang
    Fanke Jiao
    Jie Zhou
    Chen Hua
    Qian Wang
    Xia Cai
    Yang Wu
    Jie Gao
    Huan Liu
    Ge Sun
    Jan Münch
    Frank Kirchhoff
    Zhenghong Yuan
    Youhua Xie
    Fei Sun
    Shibo Jiang
    Lu Lu
    Signal Transduction and Targeted Therapy, 6
  • [7] Peptide and peptide-based inhibitors of SARS-CoV-2 entry
    Schuetz, Desiree
    Ruiz-Blanco, Yasser B.
    Muench, Jan
    Kirchhoff, Frank
    Sanchez-Garcia, Elsa
    Mueller, Janis A.
    ADVANCED DRUG DELIVERY REVIEWS, 2020, 167 : 47 - 65
  • [8] SARS-CoV-2 fusion-inhibitory lipopeptides maintain high potency against divergent variants of concern including Omicron
    Zhu, Yuanmei
    Dong, Xiaojing
    Liu, Nian
    Wu, Tong
    Chong, Huihui
    Lei, Xiaobo
    Ren, Lili
    Wang, Jianwei
    He, Yuxian
    EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 1819 - 1827
  • [9] Evaluation of Potential Peptide-Based Inhibitors against SARS-CoV-2 and Variants of Concern
    Boshah, Hattan
    Samkari, Faris
    Valle-Perez, Alexander U.
    Alsawaf, Sarah M.
    Aldoukhi, Ali H.
    Bilalis, Panayiotis
    Alshehri, Salwa A.
    Susapto, Hepi H.
    Hauser, Charlotte A. E.
    BIOMED RESEARCH INTERNATIONAL, 2023, 2023
  • [10] Montelukast and Telmisartan as Inhibitors of SARS-CoV-2 Omicron Variant
    Mulgaonkar, Nirmitee
    Wang, Haoqi
    Zhang, Junrui
    Roundy, Christopher M.
    Tang, Wendy
    Chaki, Sankar Prasad
    Pauvolid-Correa, Alex
    Hamer, Gabriel L.
    Fernando, Sandun
    PHARMACEUTICS, 2023, 15 (07)
12345